BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hematopoietic cell
,
Trichostatin A
,
rs3825942
,
SNCA
,
Fatty acid metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
BCL- 2
Summary
General Info
Curated Studies
Most Correlated Studies
Tumors derived from atg5-/- Bcl-2 iBMK cells expressing p62
Surviving Sepsis: Bcl-2 Overexpression Modulates Splenocyte Transcriptional Responses
Bcl-2 inhibiton in peripheral blood of chronic lymphocytic leukemia patients
Keratinocytes HaCat cell line with BCL-3 overexpression
Embryonic stem cells overexpressing BCL-XL with induced AKAP-13 shRNA knockdown
Explore Curated Studies Results
Literature
Most Relevant Literature
B-cell lymphoma-2 family proteins in the crosshairs: Small molecule inhibitors and activators for ca…
Impact of BCL-2 Expression on Course of Disease in Neuroblastoma.
Exosomes of endothelial progenitor cells repair injured vascular endothelial cells through the Bcl2/…
Hepatoprotective potential of taxifolin in type 2 diabetic rats: modulation of oxidative stress and …
Molecular-Scale Investigations Reveal the Effect of Natural Polyphenols on BAX/Bcl-2 Interactions.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Use of Venetoclax as Single Agent in Patients With Relapsed/Refractory BCL-2 Positive Peripheral T C…
Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer
Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhi…
Study of Bcl-2 Inhibitor BGB-11417 in Participants With Mature B-Cell Malignancies
Phase 1 Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ